share_log

Benchmark Reiterates Buy on Proto Labs, Maintains $45 Price Target

Benzinga Real-time News ·  Feb 13, 2023 07:33

Benchmark analyst Robert Wasserman reiterates Proto Labs (NYSE:PRLB) with a Buy and maintains $45 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment